Cargando…
Loss of dysbindin-1, a risk gene for schizophrenia, leads to impaired group 1 metabotropic glutamate receptor function in mice
The expression of dysbindin-1, a protein coded by the risk gene dtnbp1, is reduced in the brains of schizophrenia patients. Evidence indicates a role of dysbindin-1 in dopaminergic and glutamatergic transmission. Glutamatergic transmission and plasticity at excitatory synapses is critically regulate...
Autores principales: | Bhardwaj, Sanjeev K., Ryan, Richard T., Wong, Tak Pan, Srivastava, Lalit K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374471/ https://www.ncbi.nlm.nih.gov/pubmed/25859193 http://dx.doi.org/10.3389/fnbeh.2015.00072 |
Ejemplares similares
-
Schizophrenia-related dysbindin-1 gene is required for innate immune response and homeostasis in the developing subventricular zone
por: Al-Shammari, Abeer R., et al.
Publicado: (2018) -
Dysbindin-1 Involvement in the Etiology of Schizophrenia
por: Wang, Haitao, et al.
Publicado: (2017) -
Dysbindin-1, BDNF, and GABAergic Transmission in Schizophrenia
por: Jun, Rachel, et al.
Publicado: (2022) -
The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia
por: Maj, Carlo, et al.
Publicado: (2016) -
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
por: Maksymetz, James, et al.
Publicado: (2017)